1. Home
  2. PBH vs CBUS Comparison

PBH vs CBUS Comparison

Compare PBH & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prestige Consumer Healthcare Inc.

PBH

Prestige Consumer Healthcare Inc.

HOLD

Current Price

$61.48

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Cibus Inc.

CBUS

Cibus Inc.

HOLD

Current Price

$1.63

Market Cap

69.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBH
CBUS
Founded
1996
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
69.9M
IPO Year
2005
2017

Fundamental Metrics

Financial Performance
Metric
PBH
CBUS
Price
$61.48
$1.63
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$86.40
$20.00
AVG Volume (30 Days)
429.1K
168.2K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.04
N/A
Revenue
$1,110,479,000.00
$3,794,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.50
$109.96
P/E Ratio
$15.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.25
$1.09
52 Week High
$90.04
$4.24

Technical Indicators

Market Signals
Indicator
PBH
CBUS
Relative Strength Index (RSI) 56.45 57.01
Support Level $59.52 $1.50
Resistance Level $62.14 $1.75
Average True Range (ATR) 1.55 0.14
MACD 0.32 0.04
Stochastic Oscillator 86.90 69.23

Price Performance

Historical Comparison
PBH
CBUS

About PBH Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

About CBUS Cibus Inc.

Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.

Share on Social Networks: